Do analysts prefer BFRG or ATNM?

Actinium Pharmaceuticals has a consensus price target of $4.50, indicating a potential upside of 305.41%. Given Actinium Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Actinium Pharmaceuticals is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Actinium Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00

Is BFRG or ATNM more profitable?

Actinium Pharmaceuticals' return on equity of -100.85% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -217.80% -174.57% Actinium Pharmaceuticals N/A -100.85% -47.89%

Does the media prefer BFRG or ATNM?

In the previous week, Actinium Pharmaceuticals had 6 more articles in the media than Bullfrog AI. MarketBeat recorded 7 mentions for Actinium Pharmaceuticals and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.93 beat Actinium Pharmaceuticals' score of 0.17 indicating that Bullfrog AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Actinium Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PYRGF or BFRG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor PYRGF or BFRG?

In the previous week, PyroGenesis Canada had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for PyroGenesis Canada and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.93 beat PyroGenesis Canada's score of 0.00 indicating that Bullfrog AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ATHE or BFRG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alterity Therapeutics 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, ATHE or BFRG?

Bullfrog AI has higher revenue and earnings than Alterity Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alterity Therapeutics N/A N/A -$7.87M N/A N/A Bullfrog AI $120K 81.20 -$6.50M -$0.54 N/A

Is ATHE or BFRG more profitable?

Alterity Therapeutics' return on equity of 0.00% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Alterity Therapeutics N/A N/A N/A Bullfrog AI N/A -217.80% -174.57%

Do analysts recommend IXHL or BFRG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Incannex Healthcare 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is IXHL or BFRG more profitable?

Incannex Healthcare's return on equity of -81.01% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Incannex Healthcare N/A -81.01% -76.11% Bullfrog AI N/A -217.80% -174.57%

Do analysts recommend BFRG or INMB?

INmune Bio has a consensus target price of $8.00, indicating a potential upside of 492.59%. Given INmune Bio's stronger consensus rating and higher possible upside, analysts clearly believe INmune Bio is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 INmune Bio 2 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.17

Which has preferable earnings and valuation, BFRG or INMB?

Bullfrog AI has higher revenue and earnings than INmune Bio. Bullfrog AI is trading at a lower price-to-earnings ratio than INmune Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bullfrog AI $120K 81.20 -$6.50M -$0.54 N/A INmune Bio $50K 717.66 -$45.93M -$1.67 N/A

Is BFRG or INMB more profitable?

INmune Bio's return on equity of -103.03% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -217.80% -174.57% INmune Bio N/A -103.03% -77.66%

Does the media prefer BFRG or INMB?

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. INmune Bio's average media sentiment score of 0.94 beat Bullfrog AI's score of 0.93 indicating that INmune Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive INmune Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Bullfrog AI (BFRG) Competitors

$0.77 +0.04 (+5.41%)

Closing price 04:00 PM Eastern

Extended Trading

$0.74 -0.03 (-3.86%)

As of 07:04 PM Eastern

Compare

BFRG vs. ATNM, PYRGF, ATHE, IXHL, and INMB

Should you buy Bullfrog AI stock or one of its competitors? MarketBeat compares Bullfrog AI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bullfrog AI include Actinium Pharmaceuticals (ATNM), PyroGenesis Canada (PYRGF), Alterity Therapeutics (ATHE), Incannex Healthcare (IXHL), and INmune Bio (INMB). These companies are all part of the "pharmaceutical products" industry.

How does Bullfrog AI compare to Actinium Pharmaceuticals?

Bullfrog AI (NASDAQ:BFRG) and Actinium Pharmaceuticals (NYSE:ATNM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Actinium Pharmaceuticals has a consensus price target of $4.50, indicating a potential upside of 305.41%. Given Actinium Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Actinium Pharmaceuticals is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Actinium Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Actinium Pharmaceuticals had 6 more articles in the media than Bullfrog AI. MarketBeat recorded 7 mentions for Actinium Pharmaceuticals and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.93 beat Actinium Pharmaceuticals' score of 0.17 indicating that Bullfrog AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Actinium Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Bullfrog AI has higher revenue and earnings than Actinium Pharmaceuticals. Actinium Pharmaceuticals is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	81.20	-$6.50M	-$0.54	N/A
Actinium Pharmaceuticals	$90K	386.96	-$48.82M	-$0.75	N/A

Bullfrog AI has a beta of -2.89, meaning that its stock price is 389% less volatile than the broader market. Comparatively, Actinium Pharmaceuticals has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market.

Actinium Pharmaceuticals' return on equity of -100.85% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
Actinium Pharmaceuticals	N/A	-100.85%	-47.89%

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 27.5% of Actinium Pharmaceuticals shares are owned by institutional investors. 25.2% of Bullfrog AI shares are owned by company insiders. Comparatively, 0.6% of Actinium Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Actinium Pharmaceuticals beats Bullfrog AI on 10 of the 15 factors compared between the two stocks.

How does Bullfrog AI compare to PyroGenesis Canada?

PyroGenesis Canada (NASDAQ:PYRGF) and Bullfrog AI (NASDAQ:BFRG) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

In the previous week, PyroGenesis Canada had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for PyroGenesis Canada and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.93 beat PyroGenesis Canada's score of 0.00 indicating that Bullfrog AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bullfrog AI has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PyroGenesis Canada	-115.14%	N/A	-60.81%
Bullfrog AI	N/A	-217.80%	-174.57%

Bullfrog AI has lower revenue, but higher earnings than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PyroGenesis Canada	$9.14M	4.13	-$21.12M	-$0.04	N/A
Bullfrog AI	$120K	81.20	-$6.50M	-$0.54	N/A

PyroGenesis Canada has a beta of 0.26, meaning that its stock price is 74% less volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.89, meaning that its stock price is 389% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

0.0% of PyroGenesis Canada shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 47.7% of PyroGenesis Canada shares are owned by company insiders. Comparatively, 25.2% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

PyroGenesis Canada and Bullfrog AI tied by winning 7 of the 14 factors compared between the two stocks.

How does Bullfrog AI compare to Alterity Therapeutics?

Alterity Therapeutics (NASDAQ:ATHE) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

2.1% of Alterity Therapeutics shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 38.8% of Alterity Therapeutics shares are held by insiders. Comparatively, 25.2% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alterity Therapeutics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Alterity Therapeutics' return on equity of 0.00% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alterity Therapeutics	N/A	N/A	N/A
Bullfrog AI	N/A	-217.80%	-174.57%

Bullfrog AI has higher revenue and earnings than Alterity Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alterity Therapeutics	N/A	N/A	-$7.87M	N/A	N/A
Bullfrog AI	$120K	81.20	-$6.50M	-$0.54	N/A

In the previous week, Bullfrog AI had 1 more articles in the media than Alterity Therapeutics. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for Alterity Therapeutics. Alterity Therapeutics' average media sentiment score of 1.87 beat Bullfrog AI's score of 0.93 indicating that Alterity Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Alterity Therapeutics	Very Positive
Bullfrog AI	Positive

Alterity Therapeutics has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.89, indicating that its stock price is 389% less volatile than the broader market.

Summary

Alterity Therapeutics beats Bullfrog AI on 8 of the 11 factors compared between the two stocks.

How does Bullfrog AI compare to Incannex Healthcare?

Incannex Healthcare (NASDAQ:IXHL) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Incannex Healthcare has a beta of 7, suggesting that its share price is 600% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.89, suggesting that its share price is 389% less volatile than the broader market.

In the previous week, Bullfrog AI had 1 more articles in the media than Incannex Healthcare. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for Incannex Healthcare. Incannex Healthcare's average media sentiment score of 1.89 beat Bullfrog AI's score of 0.93 indicating that Incannex Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Incannex Healthcare	Very Positive
Bullfrog AI	Positive

0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 1.3% of Incannex Healthcare shares are held by insiders. Comparatively, 25.2% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Incannex Healthcare's return on equity of -81.01% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Incannex Healthcare	N/A	-81.01%	-76.11%
Bullfrog AI	N/A	-217.80%	-174.57%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Incannex Healthcare	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bullfrog AI has higher revenue and earnings than Incannex Healthcare. Incannex Healthcare is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Incannex Healthcare	$90K	412.83	-$46.88M	-$1.55	N/A
Bullfrog AI	$120K	81.20	-$6.50M	-$0.54	N/A

Summary

Bullfrog AI beats Incannex Healthcare on 7 of the 12 factors compared between the two stocks.

How does Bullfrog AI compare to INmune Bio?

Bullfrog AI (NASDAQ:BFRG) and INmune Bio (NASDAQ:INMB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 12.7% of INmune Bio shares are owned by institutional investors. 25.2% of Bullfrog AI shares are owned by company insiders. Comparatively, 21.4% of INmune Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Bullfrog AI has higher revenue and earnings than INmune Bio. Bullfrog AI is trading at a lower price-to-earnings ratio than INmune Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	81.20	-$6.50M	-$0.54	N/A
INmune Bio	$50K	717.66	-$45.93M	-$1.67	N/A

Bullfrog AI has a beta of -2.89, meaning that its stock price is 389% less volatile than the broader market. Comparatively, INmune Bio has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

INmune Bio's return on equity of -103.03% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
INmune Bio	N/A	-103.03%	-77.66%

INmune Bio has a consensus target price of $8.00, indicating a potential upside of 492.59%. Given INmune Bio's stronger consensus rating and higher possible upside, analysts clearly believe INmune Bio is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
INmune Bio	2 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.17

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. INmune Bio's average media sentiment score of 0.94 beat Bullfrog AI's score of 0.93 indicating that INmune Bio is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
INmune Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

INmune Bio beats Bullfrog AI on 11 of the 15 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BFRG vs. The Competition

Export

Metric	Bullfrog AI	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.74M	$1.60B	$6.44B	$12.46B
Dividend Yield	N/A	N/A	2.69%	5.22%
P/E Ratio	-1.43	78.36	23.87	24.36
Price / Sales	81.20	7.15	521.52	117.06
Price / Cash	N/A	22.87	41.27	57.13
Price / Book	4.05	4.99	9.99	6.73
Net Income	-$6.50M	-$54.76M	$3.56B	$337.03M
7 Day Performance	6.90%	0.79%	-0.89%	0.09%
1 Month Performance	N/A	N/A	N/A	-1.78%
1 Year Performance	-55.25%	0.80%	28.76%	33.98%

Bullfrog AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BFRG Bullfrog AI	0.3914 of 5 stars	$0.77 +5.4%	N/A	-57.3%	$9.74M	$120K	N/A	4
ATNM Actinium Pharmaceuticals	2.2949 of 5 stars	$1.22 flat	$4.50 +268.9%	-31.0%	$38.28M	$90K	N/A	30	News Coverage Gap Up
PYRGF PyroGenesis Canada	N/A	$0.18 -10.1%	N/A	-53.3%	$38.12M	$9.14M	N/A	90	News Coverage Gap Up
ATHE Alterity Therapeutics	1.3599 of 5 stars	$4.09 +1.7%	N/A	-13.5%	$36.28M	N/A	N/A	10	Positive News Short Interest Decrease
IXHL Incannex Healthcare	1.1205 of 5 stars	$3.03 -0.7%	N/A	-46.3%	$36.25M	N/A	N/A	3	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BFRG) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bullfrog AI (BFRG) Competitors

BFRG vs. ATNM, PYRGF, ATHE, IXHL, and INMB

How does Bullfrog AI compare to Actinium Pharmaceuticals?

Summary

How does Bullfrog AI compare to PyroGenesis Canada?

Summary

How does Bullfrog AI compare to Alterity Therapeutics?

Summary

How does Bullfrog AI compare to Incannex Healthcare?

Summary

How does Bullfrog AI compare to INmune Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bullfrog AI (BFRG) Competitors

BFRG vs. ATNM, PYRGF, ATHE, IXHL, and INMB

How does Bullfrog AI compare to Actinium Pharmaceuticals?

Do analysts prefer BFRG or ATNM?

Does the media prefer BFRG or ATNM?

Which has stronger valuation and earnings, BFRG or ATNM?

Which has more volatility & risk, BFRG or ATNM?

Is BFRG or ATNM more profitable?

Do institutionals & insiders believe in BFRG or ATNM?

Summary

How does Bullfrog AI compare to PyroGenesis Canada?

Does the media favor PYRGF or BFRG?

Is PYRGF or BFRG more profitable?

Which has stronger earnings & valuation, PYRGF or BFRG?

Which has more volatility & risk, PYRGF or BFRG?

Do analysts prefer PYRGF or BFRG?

Do institutionals & insiders have more ownership in PYRGF or BFRG?

Summary

How does Bullfrog AI compare to Alterity Therapeutics?

Do institutionals and insiders hold more shares of ATHE or BFRG?

Do analysts prefer ATHE or BFRG?

Is ATHE or BFRG more profitable?

Which has better earnings & valuation, ATHE or BFRG?

Does the media prefer ATHE or BFRG?

Which has more risk & volatility, ATHE or BFRG?

Summary

How does Bullfrog AI compare to Incannex Healthcare?

Which has more volatility & risk, IXHL or BFRG?

Does the media refer more to IXHL or BFRG?

Do insiders & institutionals have more ownership in IXHL or BFRG?

Is IXHL or BFRG more profitable?

Do analysts recommend IXHL or BFRG?

Which has preferable valuation & earnings, IXHL or BFRG?

Summary

How does Bullfrog AI compare to INmune Bio?

Do institutionals & insiders have more ownership in BFRG or INMB?

Which has preferable earnings and valuation, BFRG or INMB?

Which has more volatility & risk, BFRG or INMB?

Is BFRG or INMB more profitable?

Do analysts recommend BFRG or INMB?

Does the media prefer BFRG or INMB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools